Abogen, Inc. Overview
Pro stress-test →Abogen, Inc. is a Portland-based biotechnology company that develops non-invasive diagnostic technologies using saliva as an alternative to blood samples. Founded in 2012, the company has pioneered technology that enables cell-based research and diagnostics through saliva extraction, potentially replacing up to 80% of the five billion annual invasive blood draws.
Strategic Profile
Pro stress-test →Abogen positions itself as the world's first validated provider of saliva-based diagnostics for research and laboratory applications. The company's competitive advantage lies in its proprietary technology platform and third-party validated results, targeting the massive diagnostic sampling market with a less invasive, more patient-friendly approach.
Competitive Landscape
Pro stress-test →Direct competitors in non-invasive diagnostics are limited, but Abogen competes indirectly against traditional phlebotomy services, at-home blood testing kits (e.g., Theranos predecessors, Quest Diagnostics, LabCorp), and alternative sampling platforms. The saliva-diagnostics space is nascent with few established players.
Industry Context
Abogen, Inc. operates in Non-invasive diagnostic testing and sampling.
Key facts
Founded: 2012 · Headquarters: Portland, Maine, US · Employees: 2-10 · Revenue: $1.5M